書(shū)目名稱 | Nitric Oxide (NO) and Cancer | 副標(biāo)題 | Prognosis, Preventio | 編輯 | Benjamin Bonavida | 視頻video | http://file.papertrans.cn/667/666630/666630.mp4 | 概述 | the first volume to focus on studies that investigate the role of NO in tumor cell pathogenesis, growth, angiogenesis, response to cytotoxic therapies and NO translational applications in cancer thera | 叢書(shū)名稱 | Cancer Drug Discovery and Development | 圖書(shū)封面 |  | 描述 | .Nitric Oxide (NO) is a pleitropic, ubiquitous modulator of cellular functions. Aryl nitrite and glyceryl trinitrate, representative intravasadilators, were introduced as therapeutic agents more than a century ago for relief from acute attacks of angina. The vasodilator action is mediated by the release of NO following treatment. NO has important therapeutic applications in several diseases such as inflammatory diseases, erectile dysfunction, inflammation, pain and neural protective activity. However, the role of NO in cancer and its application in therapy has received little attention. This monograph will be the first to focus on studies that investigate the role of NO in tumor cell pathogenesis, growth, angiogenesis, response to cytotoxic therapies and NO translational applications in cancer therapy, alone or in conjunction with other therapies.. | 出版日期 | Book 2010 | 關(guān)鍵詞 | apoptosis; cancer; cancer therapy; cancer treatment; carcinogenesis; carcinoma; cell; immunotherapy; leukemi | 版次 | 1 | doi | https://doi.org/10.1007/978-1-4419-1432-3 | isbn_softcover | 978-1-4614-2611-0 | isbn_ebook | 978-1-4419-1432-3Series ISSN 2196-9906 Series E-ISSN 2196-9914 | issn_series | 2196-9906 | copyright | Springer Science+Business Media, LLC 2010 |
The information of publication is updating
|
|